Mineralys Therapeutics Expands its Board of Directors with Appointments of Glenn Sblendorio and Daphne Karydas

RADNOR, Pa., Sept. 14, 2023 -- Mineralys Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease and other...

Related Keywords

Radnor ,Pennsylvania ,United States ,Daphne Karydas ,Takeshi Takahashi ,Glenn Sblendorio ,Tom Weible ,Catalys Pacific ,Astellas Pharma ,Globenewswire Inc ,Fairleigh Dickinson University ,Elixir Health Public Relations ,Eyetech Pharmaceuticals Inc ,Harvard Advanced Management Program ,Medicines Company ,Syndax Pharmaceuticals Inc ,Intercept Pharmaceuticals Inc ,Nasdaq ,Mineralys Therapeutics Inc ,Eucrates Biomedical Acquisition Corp ,Allergan ,Logicbio Therapeutics Inc ,Pharmaceuticals Inc ,Harvard Business School ,Twitter ,Pace University ,Amicus Therapeutics Inc ,Therapeutics Inc ,Massachusetts Institute Of Technology ,Executive Chair ,Chief Financial Officer ,Flare Therapeutics ,Syndax Pharmaceuticals ,Senior Vice President ,Corporate Strategy ,Financial Planning ,Elicio Therapeutics ,Bio Therapeutics ,Eucrates Biomedical Acquisition ,Chief Executive Officer ,Executive Vice President ,Managing Director ,Intercept Pharmaceuticals ,Amicus Therapeutics ,Dickinson University ,Harvard Advanced Management ,Mineralys Therapeutics ,